Home / People / Sarah Innes
Sarah Innes

Sarah Innes


T +44 20 7067 3248
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
United Kingdom
Languages English

Sarah is a Partner whose focus is advice to clients in the life sciences sector. Sarah is experienced in contentious, non-contentious and advisory work in this sector and specialises in patent litigation and EU and UK medicines law. Sarah also has experience working in the in-house legal team of a major pharmaceutical company.

more less

Relevant experience

  • Sandoz on High Court and Court of Appeal proceedings defending a patent infringement claim in relation to a transdermal opioid patch, as well as the largest ever damages inquiry following a finding of non-infringement of a patent in the English Court.
  • Teva in relation to High Court patent revocation proceedings regarding a blockbuster oncology product.
  • A multi-national pharmaceutical company on proceedings in the EU General Court regarding regulatory data protection for an oncology product.
  • Teva in relation to Judicial Review proceedings in front of the Administrative Court concerning a marketing authorisation application for a treatment for multiple sclerosis.
  • Abbott Laboratories on High Court and Court of Appeal patent litigation in relation to coronary stents.
  • Multiple multi-national pharmaceutical companies in relation to regulatory exclusivity rights for products in development.
  • Teva on its abuse of dominance follow-on damages claim against Reckitt Benckiser in the High Court.
more less


  • 2012 – Postgraduate Diploma in Intellectual Property, Oxford University
  • 2008 – Legal Practice Course, BPP, London
  • 2007 – Graduate Diploma in Law, BPP, London
  • 2006 – MSc Biomedicine, Bioscience and Society, LSE, London
  • 2003 – BA Biological Sciences, St John’s College, Oxford University
more less


Show only
20 March 2020
UPC fal­ters again - a boost for ar­bit­ra­tion
As many of you will know, this morn­ing the Ger­man Con­sti­tu­tion­al Court ruled against the pur­por­ted rat­i­fic­a­tion by Ger­many of the European Agree­ment on a Uni­fied Pat­ent Court. This after the in­dic­a­tion...
16 December 2019
UK Su­preme Court's de­cision in Chal­lenge to Ar­bit­ra­tion of Glob­al FRAND...
On 21 Oc­to­ber the UK Su­preme Court star­ted to con­sider wheth­er an Eng­lish court has the jur­is­dic­tion to settle the terms world­wide, not just for the UK, of a FRAND li­cence of Stand­ard Es­sen­tial Pat­ents....